Objective: To investigate quantitative regional distribution and hemispheric asymmetry of TDP-43 (TAR DNA-binding protein 43) inclusions, neurons, and activated microglia in primary progressive aphasia (PPA) with progranulin (GRN) mutations, and to determine concordance between distribution of pathology, clinical phenotype, and known atrophy patterns.
disease phenotype, and patterns of cortical atrophy, have not received extensive experimental attention.
In an earlier case study, we described the relationship between TDP-43 inclusions and disease phenotype in a patient with PPA carrying the GRN mutation. 12 Greater numbers of inclusions were observed in cortical areas affiliated with language function in the left hemisphere, when compared with the right, and when compared with the hippocampus, a memory-related area, in either hemisphere. This distribution pattern is consistent with progressive language deficits displayed by patients with PPA. 1, 13 In the present study, we investigated the distribution of cortical TDP-43 inclusions and neurons in 4 participants with PPA carrying GRN mutations (including the previously reported case). Given the normal immunologic role of the progranulin (PGRN) protein, we also quantitatively analyzed the distribution of activated microglia in the same participants. Finally, we determined the relationship between quantitative measures of pathology and known patterns of atrophy based on reports in the literature.
METHODS Participant information. Four Caucasian, right-handed participants were analyzed in this study. Further characteristics of the participants, including clinical course, are summarized in tables 1, e-1, and e-2 on the Neurology ® Web site at Neurology.org.
The root diagnosis of PPA was rendered using an extensive battery of neuropsychological tests and criteria described previously. 1, 3 Briefly, patients were required to have had insidious onset and gradual progression of a language impairment, manifested by deficits in word finding, word usage, word comprehension, or sentence construction. The aphasia should have initially arisen as the most salient impairment and as the principal factor underlying the disruption of activities of daily living.
Clinical PPA subtypes were identified based on published criteria.
14 Participants 1 and 2 displayed the agrammatic variant of PPA (tables 1 and e-1), characterized by disrupted sentence production, including abnormal word order, poor phrase structure, and misuse of grammatical morphemes. Participants 3 and 4 were classified as logopenic PPA, characterized by word retrieval deficits that lead to intermittent loss of verbal fluency. For each stain, 5 adjacent sections per area were used for stereological analysis using the optical fractionator method and the Stereo Investigator software (MBF Bioscience, MicroBrightField, Williston, VT), by an observer blinded to participant, cortical area, and hemisphere as previously described. 15 The top and bottom 1 mm of each section was designated as guard height. The boundaries of each cortical area were delineated at 13 magnification and counting was performed at 603. The specific parameters used in this investigation were derived from pilot studies on a subsample of participants to determine optimal settings that would result in coefficient of error less than 0.1.
Statistical analysis. Density of TDP-43 inclusions, NeuN
immunoreactive neurons, and activated microglia were compared across areas and hemispheres using mixed linear models taking into account repeated measures within samples and nonnormality of the data. Post hoc comparisons were done using pairwise t tests. Spearman correlation analyses were used to determine relationships between measures.
RESULTS All cortical areas examined contained TDP-43 inclusions, NeuN immunoreactive neurons, and activated microglia (figures 1-4). While TDP-43-positive NII, NCI, and short/thin DN were present in each brain, the overall density of DN was considerably higher than the other inclusions (figures 1A and 2A). In the 4 participants, the density of cortical DN was 11-to 35-fold higher than the density of NII (p , 0.05) and 2-to 5-fold higher than the density of NCI. The density of NCI was 3-to 6-fold higher than the density of NII. This pattern of inclusion density is consistent with FTLD-TDP type A. 16, 17 NeuN immunoreactivity was observed in neuronal nuclei and cytoplasm (figures 1C and 2C) while HLA-DR immunoreactivity was present in enlarged microglia and their processes (figures 1E and 2E).
The numerical density of immunoreactive elements displayed considerable variation among cortical areas, and this variation was not uniform across participants. In participants 1 and 2, classified as the agrammatic subtype of PPA, the highest densities of TDP-43 inclusions were encountered in the language regions of the frontal cortex (IFG or MFG, figure 3), while in participants 3 and 4, categorized as logopenic PPA, the highest densities of inclusions were seen in the parietal language area (IPL, figure 4 ). Other regions displayed lower densities of inclusions and the HIP consistently displayed among the lowest densities. The regional densities of NeuN immunoreactive neurons in language areas generally displayed a pattern opposite to TDP-43 inclusions. Activated microglia exhibited the least variation across participants and cortical areas primarily due to high densities in many regions (figures 3 and 4). Nevertheless, in 2 of the 4 participants (participants 1 and 4), cortical areas with the highest densities of inclusions also had the highest densities of activated microglia. Furthermore, higher densities of activated microglia showed significant correspondence to higher densities of TDP-43 inclusions (r 5 0.43, p , 0.01) and lower densities of NeuN immunoreactive neurons (r 5 20.34, p , 0.05).
Hemispheric asymmetry of pathology. With few exceptions, cortical areas in the left hemisphere displayed higher densities of TDP-43 inclusions and activated microglia, and lower densities of NeuN immunoreactive neurons (figures 1-4). In instances in which the densities did not follow the pattern described, the 2 hemispheres displayed nearly equal Relationship of pathology to known patterns of atrophy.
Cortical atrophy in PPA varies based on predominant clinical symptoms and subtype (agrammatic, logopenic, or semantic). Specifically, structural MRI studies indicate that at first visit, patients who have the agrammatic subtype of PPA display peak atrophy in IFG and MFG, as well as in superior and middle temporal gyri, and patients who have the logopenic subtype display peak atrophy in the IPL, and posterior aspects of all temporal gyri, within the left hemisphere. 2, 13, 18 Atrophy spreads to encompass the entire perisylvian language network at 2-year follow-up. However, the hemispheric asymmetry remains, the above regions continue to display substantial atrophy, and significant atrophy is confined to the language network.
While quantitative structural MRI data were not available from the 4 participants reported in this study, the distribution pattern of peak pathology Density of cortical pathology in participants with logopenic PPA Density of TDP-43 inclusions, NeuN immunoreactive neurons, and activated microglia within the cortical areas examined in the 2 participants with logopenic PPA. Note the general asymmetry of pathology favoring the left hemisphere, the peak density of inclusions and relatively low density of neurons in the language area IPL in the left hemisphere, and the lowest densities of inclusions in the HIP, a memory-related region. HIP 5 entorhinal cortex/hippocampus; IFG 5 inferior frontal gyrus; IPL 5 inferior parietal lobule; ITG 5 inferior temporal gyrus; MFG 5 middle frontal gyrus; STG 5 superior temporal gyrus.
was generally concordant with the initial pattern of atrophy summarized above. Peak density of TDP-43 inclusions was observed in one of the areas known to display atrophy in each subtype. Thus, in the 2 participants classified as agrammatic subtype of PPA (participants 1 and 2), the highest densities of TDP-43 inclusions were observed in IFG or MFG, and in the 2 logopenic participants, the highest density of inclusions were seen in IPL ( figures 3 and 4) . Hemispheric asymmetry of pathology was also most pronounced in the regions discussed above. When data from areas of peak expected atrophy with the highest densities of TDP-43 inclusions in the left hemisphere were pooled in the 4 participants (IFG and MFG in agrammatic participants and IPL in logopenic participants), significantly greater density of TDP-43 inclusions was observed in these left hemisphere areas when compared with all cortical regions on the right (p , 0.009), and the difference approached significance when such areas on the left were compared with the remainder of cortical areas on the left (p , 0.06). Conversely, density of NeuN immunoreactive neurons in these areas on the left was significantly smaller than all other areas on the right (p , 0.001) and was generally at the same level when compared with the remainder of areas on the left (p . 0.05). Similar comparisons of activated microglia density did not reach statistical significance (p . 0.05).
DISCUSSION Aggregation and propagation of misfolded proteins in the form of abnormal inclusions is a common feature of neurodegenerative diseases. The exact relationships of the resultant inclusions to neuronal loss and cortical atrophy are incompletely understood. In some settings, such as Huntington disease, the Huntingtin inclusions may reflect neuroprotective processes. 19 In other neurodegenerative disorders, such as Alzheimer disease, the phosphorylated tau precipitates in the neurofibrillary tangles are thought to trigger neuronal death so that neurofibrillary tangle densities become tightly correlated with regional atrophy and dysfunction. 20, 21 In the present study of a relatively small sample of participants, greater densities of inclusions in specific cortical areas in PPA-TDP with GRN mutations corresponded to lower densities of NeuN immunoreactive neurons, and to a smaller extent, higher densities of activated microglia. Substantially greater densities of inclusions and activated microglia, and lower densities of neurons, were encountered in cortical areas in the left hemisphere compared with areas on the right. Within the left hemisphere, the numerical densities of inclusions and to a smaller extent activated microglia were greater in cortical areas affiliated with language function than areas associated with memory. In the agrammatic subtype (participants 1 and 2) , the highest densities of TDP-43 inclusions were observed in IFG or MFG, and in the logopenic participants, the highest density of inclusions was seen in the left IPL. This distribution is consistent with subtype-specific peak atrophy sites. Therefore, the distribution of pathology in these participants displays concordance with the clinical PPA phenotype, characterized by predominant abnormalities in language function mediated by the language-dominant left hemisphere in righthanded individuals. 1 There were notable variations among participants, particularly in the overall density of TDP-43 inclusions. Thus, participant 1 (agrammatic PPA) and participant 3 (logopenic PPA) displayed substantially lower densities of TDP-43 inclusions than did participants 2 or 4. At present, the relationship between variations in the overall density of TDP-43 inclusions and clinical presentation is unknown. There were no clear differences in clinical presentation among the participants other than the PPA subtype. However, it is noteworthy that participant 4, a logopenic PPA with higher density of TDP-43 inclusions, displayed abnormalities in several neuropsychological tests (table e-2) not observed in the second logopenic participant. In participants 1 and 2 with agrammatic PPA, the highest density and asymmetry of TDP-43 inclusions were observed in MFG and IFG, respectively, both of which display peak atrophy in this PPA subtype. This distribution pattern suggests that pathology in cortical areas that partially disconnect language regions (in this case disrupting access of IFG to a normal functioning MFG) is sufficient to produce a language deficit. Finally, consistent with the spread of pathology to other language regions as disease progresses, IPL showed the second highest density and asymmetry of TDP-43 inclusions in agrammatic participant 2.
In this study, TDP-43 pathology and GRN mutations were associated with 2 different PPA clinical subtypes. This finding is consistent with our recent observations in 6 participants with PPA who had type-A TDP pathology.
3 Four of the 6 participants in that study presented clinically as logopenic PPA, while the remaining 2 were of the agrammatic subtypes, and one participant per subtype had a GRN mutation. Another study of 6 participants with agrammatic PPA 22 reported that all had the postmortem diagnosis of FTLD-TDP, and 4 had GRN mutations. Thus, while TDP pathology with GRN mutations can result in the agrammatic subtype of PPA, it can alternatively result in logopenic PPA.
Among other functions, the PGRN protein is involved in immunity and acts in an antiinflammatory manner. 23 PGRN is present in microglia, 24 acts as a chemoattractant for microglia recruitment, 25 stimulates microglia endocytic activity, 25 and is increased in neuroinflammatory conditions. 24 It binds to tumor necrosis factor receptors, interferes with the interaction of the potentially cytotoxic tumor necrosis factor a with its receptors and is thereby therapeutic against inflammatory arthritis in mice. 26 Haploinsufficiency caused by GRN mutations in FTLD-TDP results in significantly elevated serum levels of the proinflammatory cytokine interleukin 6 compared with patients without the GRN mutation. 27 Finally, PGRN deficiency promotes neuroinflammation through microglia activation, resulting in enhanced neuronal loss in experimentally induced damage, 28 and causes exaggerated inflammation in mice. 29 Thus, microglia activation and inflammation are likely involved in the neurodegenerative process in FTLD-and PPA-TDP, at least in those with GRN mutations.
In the present study of participants with PPA and GRN mutations, densities of activated microglia did not show the same pronounced differences among cortical areas as did the densities of inclusions and neurons, and they did not reliably identify cortical regions of greatest atrophy. One potential factor contributing to these results may be overall increased activation of microglia throughout the cerebral cortex mediated by reduced PGRN protein. Thus, regardless of the extent of other pathology, microglia would show exacerbated activation across all cortical areas affected. It is equally possible that microglia show a pronounced and early response to TDP-43 pathology and neuronal loss and are maximally activated regardless of the degree of pathology or GRN mutation. Testing these possibilities must await investigation of microglia activation in participants with PPA but without GRN mutations. In the present study, the density of microglia did show significant correlations with the densities of inclusions and neurons, reinforcing the possibility that microglia may make a significant contribution to cortical abnormalities in PPA and FTLD with GRN mutations. Despite the lowest densities of TDP-43 inclusions, the hippocampus contained substantial densities of microglia. It remains to be determined whether this disproportionate distribution of microglia is related to GRN mutations.
Cortical neuronal loss is an established feature of FTLD. 16, 30 However, quantitative regional variations in loss of neurons has not received experimental attention in FTLD-TDP. Investigations in transgenic animal models have demonstrated a relationship between human TDP-43 overexpression and loss of cortical neurons. [31] [32] [33] Nearly all assessments of neuronal loss in FTLD-TDP, including PPA-TDP, have used qualitative rankings. An investigation of TDP-43 inclusions using nonstereological quantitative techniques showed no significant differences in the density of remaining neurons in the MFG, ITG, and HIP. 34 The only unbiased stereological investigation of regional loss of cortical neurons in FTLD-TDP found significant loss of neurons in the parolfactory cortex when compared to controls. 35 The present study utilized unbiased stereological analysis of the status of cortical neurons in PPA-TDP. Significantly lower densities of neurons were encountered in cortical areas of the left hemisphere, and this asymmetry attained its peak in at least one cortical area known to undergo peak atrophy in each PPA subtype. However, it should be noted that the measures obtained in the present study are not based on comparisons with the normal contingent of neurons in each brain area. Therefore, definitive conclusions must await investigations that include an age-matched control group. Nonetheless, our results point to likely regional and hemispheric differences in the extent of neuronal loss in PPA that display concordance with disease phenotype and PPA subtype.
Extracellular inclusions have not been reported in FTLD-TDP. Therefore, it is assumed that inclusions disappear as neurons are lost. Our findings of increased numbers of inclusions in areas of neuronal loss would suggest that areas with greatest neuronal loss have higher propensity for inclusion formation and new inclusions are generated as old ones disappear with dying neurons. Based on accepted pathologic criteria, FTLD-TDP type A is associated with infrequent NCI and NII and predominance of short, thin DN. It is possible that in FTLD-TDP type A, the lower numbers of NCI and NII are caused by loss of neurons.
The results of the present study demonstrate regional and hemispheric distribution of pathology in PPA-TDP that is concordant with disease phenotype and subtype-specific patterns of atrophy. We have demonstrated similar asymmetric distribution of plaques and tangles in PPA participants with Alzheimer disease pathology. 15 Therefore, it appears that the PPA phenotype is determined by the anatomical distribution of neurodegeneration rather than the cellular and molecular nature of the pathology.
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